Search results for "Dopamine receptors"

showing 7 items of 7 documents

Reduction of red-green discrimination by dopamine D1 receptor antagonists and retinal dopamine depletion

1996

AbstractReduction of wavelength discrimination ability in the 560–640 nm range, but not in the 404–540 nm range, has been demonstrated in goldfish after intravitreal injection of D1-dopamine receptor antagonists. Intravitreal injection of the dopaminergic neurotoxin 6-OH-dopamine severely reduced wavelength discrimination ability in the 540–661 nm range within 3 days. Discrimination ability could be reconstituted by the Dl-agonist SKF 38393. Animals recovered from injection of 6-OH-dopamine within 14–16 days. No change of wavelength discrimination was induced by 6-OH-dopamine in the 461–540 nm range. We conclude that under photopic conditions dopamine modulates retinal mechanisms involved i…

DopamineWavelength discriminationRetinaHydroxydopamineschemistry.chemical_compoundDiscrimination PsychologicalDopamine receptor D1OpticsDopamineGoldfishmedicineAnimalsNeurotoxinDopamine receptorsNeurotransmitterRetinabusiness.industryReceptors Dopamine D1DopaminergicRetinalSensory SystemsOphthalmologymedicine.anatomical_structurechemistryDopamine receptorDopamine AgonistsBiophysicssense organsbusinessColor Perceptionmedicine.drugVision Research
researchProduct

The multiple roles of dopamine receptor activation in the modulation of gastrointestinal motility and mucosal function

2022

Dopamine (DA) is a catecholamine regulatory molecule with potential role in physiology and physiopathology of the intestinal tract. Various cellular sources of DA have been indicated as enteric neurons, immune cells, intestinal flora and gastrointestinal epithelium. Moreover, DA is produced by nutritional tyrosine. All the five DA receptors, actually described, are present throughout the gut. Current knowledge of DA in this area is reviewed, focusing on gastrointestinal function in health and during inflammation. Research on animal models and humans are reported. A major obstacle to understanding the physiologic and/or pharmacological roles of enteric DA is represented by the multiplicity o…

InflammationGastrointestinal inflammationCellular and Molecular NeuroscienceCatecholaminesGastrointestinal motilityEndocrine and Autonomic SystemsDopamineHumansAnimalsGastrointestinal transportNeurology (clinical)Dopamine receptorsReceptors DopamineAutonomic Neuroscience
researchProduct

Involvement of Dopamine D2 Receptors in Addictive-Like Behaviour for Acetaldehyde

2014

Acetaldehyde, the first metabolite of ethanol, is active in the central nervous system, where it exerts motivational properties. Acetaldehyde is able to induce drinking behaviour in operant-conflict paradigms that resemble the core features of the addictive phenotype: drug-intake acquisition and maintenance, drug-seeking, relapse and drug use despite negative consequences. Since acetaldehyde directly stimulates dopamine neuronal firing in the mesolimbic system, the aim of this study was the investigation of dopamine D2-receptors' role in the onset of the operant drinking behaviour for acetaldehyde in different functional stages, by the administration of two different D2-receptor agonists, q…

MaleIndoleslcsh:MedicinePharmacologyBehavioral Neurosciencechemistry.chemical_compoundquinpiroleMedicine and Health Scienceslcsh:ScienceNeuropharmacologyDrug DependenceMultidisciplinaryDopaminergicD2 dopamine receptorsAcetaldehyde; Operant self-administration; D2 dopamine receptors; quinpiroleNeurologyBehavioral PharmacologyDopamine AgonistsSignal TransductionResearch Articlemedicine.drugAlcohol DrinkingDrug-Seeking BehaviorAcetaldehydeAddictive-Like BehaviourNeuropharmacologyQuinpiroleDopamineDopamine receptor D2medicineAnimalsRats WistarAcetaldehyde; Addictive-Like Behaviour; Dopamine D2 ReceptorsPharmacologyOperant self-administrationEthanolReceptors Dopamine D2Neurotransmissionlcsh:RAcetaldehydeBiology and Life SciencesDopamine D2 ReceptorsRatsRopinirolePharmacodynamicschemistrySettore BIO/14 - FarmacologiaConditioning Operantlcsh:QNeurosciencePLoS ONE
researchProduct

Role of dopamine neurotransmission in the long-term effects of repeated social defeat on the conditioned rewarding effects of cocaine

2016

Numerous studies report that social defeat stress alters dopamine (DA) neurotransmission in several areas of the brain. Alterations of the mesolimbic dopaminergic pathway are believed to be responsible for the increased vulnerability to drug use observed as a result of social stress. In the present study, we evaluated the influence of DA receptors on the long-term effect of repeated social defeat (RSD) on the conditioned rewarding and reinstating effects of cocaine. For this purpose, the D1R antagonist SCH 23390 and the D1R antagonist raclopride were administered 30 min before each social defeat and a cocaine-induced CPP procedure was initiated three weeks later. The expression of the D1R a…

Malemedicine.medical_specialtyHippocampusStatistics NonparametricReceptors DopamineSocial defeatMice03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDopamine Uptake InhibitorsRewardCocaineInternal medicineDopamine receptor D2medicineAnimalsDopamine receptorsBiological PsychiatryCerebral CortexPharmacologyRacloprideSocial stressSCH-23390Dose-Response Relationship DrugDopaminergicAge FactorsBenzazepinesConditioned place preferenceConditioned place preference030227 psychiatryDisease Models AnimalEndocrinologychemistryRacloprideDopamine receptorAnesthesiaConditioning OperantDopamine AntagonistsPsychologySocial defeat stressStress Psychological030217 neurology & neurosurgerymedicine.drug
researchProduct

2,3,9- and 2,3,11-Trisubstituted tetrahydroprotoberberines as D2 dopaminergic ligands

2013

Dopamine-mediated neurotransmission plays an important role in relevant psychiatric and neurological disorders. Nowadays, there is an enormous interest in the development of new dopamine receptors (DR) acting drugs as potential new targets for the treatment of schizophrenia or Parkinson's disease. Previous studies have revealed that isoquinoline compounds such as tetrahydroisoquinolines (THIQs) and tetrahydroprotoberberines (THPBs) can behave as selective D-2 dopaminergic alkaloids since they share structural similarities with dopamine. In the present study we have synthesized eleven 2,3,9- and 2,3,11-trisubstituted THPB compounds (six of them are described for the first time) and evaluated…

Models MolecularBerberineStereochemistryCell SurvivalMTT and cytofluorometric analysisTheoretical calculationsMolecular Dynamics SimulationLigandsCiencias BiológicasCompostos orgànics SíntesiDrug DiscoveryAlcaloidesDopamina ReceptorsAnimalsHumansTetrahydroprotoberberinesDopamine receptorsStructure-activity relationships cytotoxicityPharmacologyMolecular StructureChemistryReceptors Dopamine D2Organic ChemistryDopaminergicGeneral MedicineBioquímica y Biología MolecularRatsDopamine receptorStructureeactivity relationships cytotoxicityQuímica orgànicaCIENCIAS NATURALES Y EXACTAS
researchProduct

1-(2′-Bromobenzyl)-6,7-dihydroxy-N-methyl-tetrahydroisoquinoline and 1,2-Demethyl-nuciferine as Agonists in Human D2 Dopamine Receptors

2020

Certain D2-like dopamine receptor (DR) agonists are useful therapeutically as antiparkinsonian drugs, whereas D2-like DR antagonists or partial agonists are proven effective as antipsychotics. Two ...

PharmacologyD2 dopamine receptorsAntiparkinsonian drugsNuciferine010405 organic chemistryTetrahydroisoquinolineOrganic ChemistryPharmaceutical SciencePharmacology01 natural sciencesPartial agonist0104 chemical sciencesAnalytical Chemistry010404 medicinal & biomolecular chemistrychemistry.chemical_compoundComplementary and alternative medicinechemistryDopamine receptorDrug DiscoveryMolecular MedicineJournal of Natural Products
researchProduct

Structure-activity relationship of dopaminergic halogenated 1-benzyl-tetrahydroisoquinoline derivatives

2009

Two series of halogenated 1-benzyl-7-chloro-6-hydroxy-tetrahydroisoquinolines were prepared to explore the influence of each series on the affinity for dopamine receptors. All the compounds displayed a high affinity for D(1)-like and/or D(2)-like dopamine receptors in striatal membranes, although they were unable to inhibit [(3)H]-dopamine uptake in striatal synaptosomes. The halogen placed on the benzylic ring in 1-benzyl-THIQs, compounds of the series 1, 2'-bromobenzyl derivatives with K(i) values into the nanomolar range, and the series 2, 2',4'-dichlorobenzyl-THIQ homologues, proves to be an important factor to modulate affinity at dopamine receptor. (C) 2009 Elsevier Masson SAS. All ri…

inorganic chemicalsHalogenationStereochemistryChemical synthesisReceptors DopamineStructure-Activity Relationshipchemistry.chemical_compoundStructure–activity relationshipsDopamineTetrahydroisoquinolinesBiogenic amineDrug DiscoverymedicineAnimalsStructure–activity relationshipRats WistarNeurotransmitterDopamine receptorsSTRUCTURE-ACTIVITY RELATIONSHIPSPharmacologychemistry.chemical_classification1-Halogenated benzyl-7-chloro-6-hydroxy-tetrahydroisoquinolinesDopamine uptakReceptors Dopamine D2Receptors Dopamine D1Otras Ciencias QuímicasOrganic ChemistryDopaminergicCiencias QuímicasGeneral MedicineBinding1-Halogenated benzyl-7-chloro-6-hydroxytetrahydroisoquinolinesRatschemistryDopamine receptorDOPAMINE UPTAKECatecholamineFemaleCIENCIAS NATURALES Y EXACTASProtein Bindingmedicine.drug
researchProduct